The accompanying exhibition took place virtually as part of the 16th National Conference on Health Economy. As in previous years, this gave conference participants an insight into the healthcare industry in our state.
The German-Israeli Helmholtz International Laboratory aeroHEALTH strives to understand the biological and health effects of atmospheric aerosols mechanistically and to combine information on primary emissions as well as secondary and ambient aerosols. Atmospheric change ("ageing") under atmospherically relevant conditions of biogenic and anthropogenic emissions is simulated in short- and long-term experiments to link laboratory observations with observed health effects from field experiments.
Whether you need compute power, database storage, content delivery or other capabilities, AWS provides the services to help you build demanding applications with increasing flexibility, scalability and reliability.
AMEOS secures healthcare in the regions: At over 50 locations in our hospitals, polyclinics, rehabilitation, nursing and integration facilities, we are pioneers in medicine and care. AMEOS stands for comprehensive and future-proof care for the broad population in regional networks. Because for AMEOS, the most important thing is health.
AOK Nordost is a reliable partner for people in Berlin, Brandenburg and Mecklenburg-Western Pomerania. As a leading regional health insurer, we focus on customer proximity and digital transformation. Together with our partners in the health care sector, we create customized care solutions for our policyholders in a strong network.
Bayer AG is a life science company with a history of more than 150 years and core competencies in the fields of health care and agriculture. Bayer is represented worldwide by around 385 companies in 83 countries and employed 99,538 people worldwide in 2020, 23,398 of them in Germany. The headquarters of the international group is in Leverkusen. The Bayer Group is managed through the three divisions Pharmaceuticals, Consumer Health and Crop Science. The Pharmaceuticals segment focuses on prescription products, particularly in the areas of cardiovascular and women's health, and on specialty therapeutics in the areas of oncology, hematology and ophthalmology. The Consumer Health segment offers mainly non-prescription products in the categories of dermatology, nutritional supplements, pain, gastrointestinal diseases, allergies and colds. Crop Science is one of the world's leading agribusinesses and is active in seeds, crop protection and pest control.
Biobeats remote patient monitoring (RPM) health-AI platform includes a disposable short-term chest-monitor and a long-term wrist-monitor, both of which utilize a photoplethysmography-based (PPG) sensor to continuously provide accurate patient readings of 15 health parameters at once, including blood pressure, pulse rate, respiratory rate, blood oxygen saturation, stroke volume, one lead ECG (only chest-monitor) and more.
The Israeli Embassy in Berlin is the headquarters of the diplomatic representation of Israel in Germany.
Briá is a secure decentralized data exchange platform, aiming to empower life-science development, enable research data reuse and lower the entry barrier for healthcare research. Briá automates business, regulatory and curation processes, allowing simple data discovery, letting healthcare organizations to control and share their data with zero effort and zero risk.
data experts is a long-standing IT partner of various players in the German healthcare sector. Our goal is to develop innovative IT solutions for a networked healthcare system together with our customers and to make information technology usable. When developing IT solutions, we attach great importance to a partnership-based, goal-oriented and innovative exchange of ideas.
With around 4,500 employees and total assets of EUR 109.8 billion, Deutsche Kreditbank AG is one of the TOP 20 banks in Germany. We are a financing partner for hospitals, medical care centers, rehabilitation clinics, care facilities and healthcare professionals. We have already financed around 320 inpatient care facilities and 210 acute and rehabilitation clinics. With 16,000 customers, we are one of the major banks for the healthcare sector.
Using new methods, GistMD’s Personalized Patient Education Platform provides a unique patient engagement solution across a wide spectrum of patient journeys and therapeutic areas. The Platform has been proven to generate dramatic improvements in patient-engagement, leading to shortened hospital stays, reduced readmission rates, and enhanced compliance and adherence.
We are an independent, family-owned company headquartered in Aachen, Germany and represented in 29 countries in Europe, Latin America and the United States. Our products are available in around 100 countries. In 2020, Grünenthal employed around 4,500 people and generated sales of 1.3 billion euros.
HT BioImaging is a revolutionary patented medical imaging platform technology. Our mission is to detect and classify cancer early on the spot. Our exceptional team includes AI, signal analysis and computer vision experts, heat transfer & thermodynamics top researchers, oncologists, radiologists, and one successful serial entrepreneur.
Healables.io is a digital health startup with a patient-centric AI-driven health coach and wearable electroceutical for the home-based and remote treatment of sports injuries, chronic illness and chronic pain. Clinical trials for osteoarthritis, diabetic neuropathy and COVID-19 and a sports pilot with the Stade Francais Paris Rugby Club are planned for Q2/Q3 2021.
Inovytec, founded in 2011, is an innovative medical device company, developing cutting-edge solutions in the field of advanced emergency care, with a focus on respiratory and cardiac failures.
Our products are designed to increase the survivability chances of critical medical victims, where the first efficient treatment is crucial, even in harsh environments.
Leading hospitals, emergency organizations, militaries, and smart cities around the world have already implemented our solutions. We look forward to developing our partnerships and products focusing on finding new solutions that will help professionals and non-professionals to save lives.
Klinikum Karlsburg near the Hanseatic and university city of Greifswald has an excellent reputation as a specialist clinic for heart and diabetes patients. The facility offers innovative cutting-edge medicine in the diagnosis and therapy of all cardiovascular diseases, especially diseases of the coronary vessels, the heart muscle, the heart valves and cardiac arrhythmias.
We believe that developing advanced innovative solutions, based on data, will transform primary healthcare and bring great savings. We bring years of experience in leadership, creativity, data solutions implementation and innovative technologies adaption.
Our team is inspired with can-do attitude, strive to excellence culture and the will to make an impact in the digital-health arena.
With the state's Excellence Research Programme, the Ministry of Education, Science and Culture of Mecklenburg-Vorpommern aims to strengthen top-level research. Approximately €48 million from the European Social Fund will be made available for this purpose. The main goal of the programme is the professional qualification of young scientists in research networks.
neoplas med Ltd. was founded in 2009 as a spin-off of the Leibniz Institute for Plasma Research and Technology (INP) in Greifswald. In cooperation with the INP's plasma medical research, the company develops and markets solutions for patients' needs.
The first milestone is the world's first CE-certified plasma jet, the kINPen® MED for the treatment of acute and chronic wounds.
Novartis is rethinking medicine to help people live better, longer lives. As a leading global pharmaceutical company, we use scientific innovation and digital technologies to develop breakthrough therapies in areas of unmet medical need. In doing so, we regularly rank among the companies that invest the most in research and development worldwide. Novartis products reach nearly 800 million people globally, including over 17 million in Germany, and we are looking for new ways to expand access to our latest therapies.
We focus on innovative prescription medicines and generics.
Sanofi is a leading global healthcare company that helps people with their health challenges. To do this, its employees research, develop and market therapeutic solutions tailored to patients' needs. Sanofi vaccines prevent disease. The company relieves pain and suffering with innovative medicines. Sanofi cares as much about people with rare diseases as it does about the millions of people with chronic conditions.
More than 100,000 employees in 100 countries worldwide translate scientific innovation into medical progress. In Germany, there are about 9,000 employees. There are only a few healthcare companies that also research and develop innovative medicines in this country. Sanofi, with its sites in Frankfurt-Höchst, Berlin, Neu-Isenburg and Cologne, is one of them.
Sanofi, Empowering Life.
Sheba Medical Center, Israel's City of Health, is one of the most comprehensive and advanced hospitals in the world and a leading center of medical research. Sheba has been recognized by Newsweek as one of the top ten in the world for three consecutive years since 2019. Sheba is renowned for its commitment to clinical excellence and compassionate, patient-centered care, applying the most advanced technologies and medical innovations. Sheba collaborates with prominent medical institutions and universities around the world, working in close synergy with leaders in industry and with high-tech innovators to develop new medical technologies, justifying the international recognition and acclaim as one of the world’s leading medical institutions.
Techniker Krankenkasse is Germany's largest health insurance company, with more than 10 million insured. The Mecklenburg-Vorpommern regional office aims to establish our federal state as an innovation location for the health care sector. Quality and efficiency - coupled with advanced care services for our insured - are our maxims.
Greifswald University Medical School has its origins in the founding of the university on 17 October 1456, when the Faculty of Medicine was also established. Today, Greifswald University Medical School encompasses a wide-ranging spectrum of services in which 21 clinics/polyclinics, 19 institutes and other central facilities work together.
The vfa is the association of research-based pharmaceutical companies in Germany. We represent the interests of 47 of the world's leading research-based pharmaceutical companies and over 100 subsidiaries and affiliates in health, research and economic policy. The members of the vfa represent more than two thirds of the entire German pharmaceutical market and employ approximately 80,000 people in Germany.